Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lynskey

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|October 29, 2019
Public health implications of legalising the production and sale of cannabis for medicinal and recreational useWayne Hall, Daniel Stjepanović, Jonathan Caulkins, et al.
Drug and Alcohol Dependence|December 14, 2005
One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)Maree Teesson, Joanne Ross, Shane Darke, et al.
Drug and Alcohol Review|November 22, 2005
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS)Joanne Ross, Maree Teesson, Shane Darke, et al.
British Journal of Clinical Pharmacology|December 18, 2023
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trialHannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
BMJ (Clinical Research Ed.)|November 26, 2002
Cannabis use and mental health in young people: cohort studyGeorge C Patton, Carolyn Coffey, John B Carlin, et al.
Journal of Substance Abuse Treatment|April 29, 2005
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)Shane Darke, Joanne Ross, Maree Teesson, et al.
Drug and Alcohol Review|May 5, 2017
The relationship between initial route of heroin administration and speed of transition to daily heroin useLindsey A Hines, Michael Lynskey, Katherine I Morley, et al.
The Lancet. Psychiatry|February 25, 2016
Why young people's substance use matters for global healthWayne D Hall, George Patton, Emily Stockings, et al.
The Lancet. Public Health|May 27, 2023
Adverse childhood experiences and adolescent cannabis use trajectories: findings from a longitudinal UK birth cohortLindsey A Hines, Hannah J Jones, Matthew Hickman, et al.
Plos Medicine|September 30, 2009
Should burden of disease estimates include cannabis use as a risk factor for psychosis?Louisa Degenhardt, Wayne D Hall, Michael Lynskey, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|October 29, 2019
Public health implications of legalising the production and sale of cannabis for medicinal and recreational useWayne Hall, Daniel Stjepanović, Jonathan Caulkins, et al.
Drug and Alcohol Dependence|December 14, 2005
One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)Maree Teesson, Joanne Ross, Shane Darke, et al.
Drug and Alcohol Review|November 22, 2005
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS)Joanne Ross, Maree Teesson, Shane Darke, et al.
British Journal of Clinical Pharmacology|December 18, 2023
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trialHannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
BMJ (Clinical Research Ed.)|November 26, 2002
Cannabis use and mental health in young people: cohort studyGeorge C Patton, Carolyn Coffey, John B Carlin, et al.
Journal of Substance Abuse Treatment|April 29, 2005
Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)Shane Darke, Joanne Ross, Maree Teesson, et al.
Drug and Alcohol Review|May 5, 2017
The relationship between initial route of heroin administration and speed of transition to daily heroin useLindsey A Hines, Michael Lynskey, Katherine I Morley, et al.
The Lancet. Psychiatry|February 25, 2016
Why young people's substance use matters for global healthWayne D Hall, George Patton, Emily Stockings, et al.
The Lancet. Public Health|May 27, 2023
Adverse childhood experiences and adolescent cannabis use trajectories: findings from a longitudinal UK birth cohortLindsey A Hines, Hannah J Jones, Matthew Hickman, et al.
Plos Medicine|September 30, 2009
Should burden of disease estimates include cannabis use as a risk factor for psychosis?Louisa Degenhardt, Wayne D Hall, Michael Lynskey, et al.
Pageof 9